Viewing nowGleride Tablets (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Independence Bio Pharmaceutical Co., Ltd.

MFDS item code 201906153 · Approved 2019.08.29 · Insurance code 057700350
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps improve blood sugar control in patients with type 2 diabetes. It can be used as an adjunct to diet and exercise therapy. It can be used alone or, if necessary, administered in combination with oral hypoglycemic agents or insulin. Especially in cases where blood sugar control is difficult with sulfonylureas or metformin monotherapy, the effectiveness can be enhanced by using this medication alongside metformin. It is used to improve blood sugar control in conjunction with various treatment methods.
Adjust the dose individually for each patient. Swallow without chewing, with at least 1/2 glass of water. Administer this medicine orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, doses greater than 4 mg provide little additional effect, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg per day and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previous medicine should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately taking sugar. Hypoglycemia may recur after initial successful management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses need to be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a comatose state. Additionally, patients who have had allergic reactions to this medication, its components, or sulfonylureas should not be treated with this medication. There is limited experience with the use of this medication in patients with severely impaired liver or kidney function, and switching to regular insulin therapy is recommended. It is also safe for women who are pregnant or may become pregnant, as well as breastfeeding women, to avoid taking this medication. Insulin therapy is more appropriate for patients with severe infections, before and after surgery, or those who have suffered severe trauma. Patients with gastrointestinal disturbances such as diarrhea or vomiting should be cautious as they may have an increased risk of hypoglycemia due to improper food absorption. During the first week of medication, the risk of hypoglycemia is high, so blood sugar should be frequently monitored. Particularly, elderly patients, those with poor nutritional status, irregular meal patterns, or who have mismatched exercise and meal intake have a greater risk of hypoglycemia. Patients who consume alcohol frequently or have impaired kidney and liver function, as well as those with other endocrine disorders, may also be more sensitive to hypoglycemia. Caution should be exercised regarding blood sugar fluctuations if the medication is overdosed or used in conjunction with other medications. If such risk factors are present, it is important to consult with a physician to adjust the dosage or administration method. Hypoglycemia may occur with this medication, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, decreased concentration, confusion, dizziness, drowsiness, and changes in consciousness. Symptoms such as cold, sweaty skin may also appear. Severe hypoglycemia can exhibit symptoms similar to a stroke, so immediately consuming food or drink containing sugar when symptoms arise is essential. Initially taking this medication may cause temporary blurring of vision or gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea, depending on blood sugar changes. Rarely, liver function abnormalities or changes in blood cell counts may also occur, necessitating regular testing. Allergic reactions such as itching, hives, and rashes may occur, and if serious reactions like difficulty breathing or decreased blood pressure manifest, immediate medical attention is required. It is important to optimize blood sugar control by incorporating dietary and exercise therapies while taking this medication. If hypoglycemia occurs, sugar or sugary drinks should be consumed immediately to alleviate symptoms, and it is advisable to always carry sugar for emergencies. Sufficient education about symptoms of hypoglycemia and risk factors should be provided to patients and their families. Additionally, this medication may interact with other drugs, so it is crucial to inform the physician or pharmacist when starting or stopping any other medications. Caution is necessary when used with medications that may affect enzymes that metabolize drugs in the liver. Some medications may enhance or diminish the blood sugar-reducing effects of this medication, thus adherence to the physician's instructions when taking medications is essential. It is safest for pregnant or breastfeeding women to refrain from taking this medication, and it is recommended to switch to insulin therapy if necessary. The safety and efficacy of this medication have not been established in children under 18. Elderly patients should have their medication doses adjusted carefully as kidney function may be impaired. In cases of overdose, severe hypoglycemia may occur, necessitating immediate medical attention for appropriate treatment, which may include inducing vomiting, administering activated charcoal, or glucose injection. This medication should be stored out of reach of children, in its original container and tightly sealed.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture exposure. A storage temperature of 1 to 30 degrees Celsius at room temperature is recommended. This will help maintain the medication's effectiveness for a longer period.
Green, oblong tablets
For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Independence Bio Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.